Cargando…
Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice
Recent advances in gene knockout techniques and the in vivo analysis of mutant mice, together with the advent of large-scale projects for systematic mouse mutagenesis and genome-wide phenotyping, have allowed the creation of platforms for the most complete and systematic analysis of gene function ev...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255539/ https://www.ncbi.nlm.nih.gov/pubmed/22028326 http://dx.doi.org/10.1242/dmm.008334 |
_version_ | 1782221019061157888 |
---|---|
author | Schofield, Paul N. Vogel, Peter Gkoutos, Georgios V. Sundberg, John P. |
author_facet | Schofield, Paul N. Vogel, Peter Gkoutos, Georgios V. Sundberg, John P. |
author_sort | Schofield, Paul N. |
collection | PubMed |
description | Recent advances in gene knockout techniques and the in vivo analysis of mutant mice, together with the advent of large-scale projects for systematic mouse mutagenesis and genome-wide phenotyping, have allowed the creation of platforms for the most complete and systematic analysis of gene function ever undertaken in a vertebrate. The development of high-throughput phenotyping pipelines for these and other large-scale projects allows investigators to search and integrate large amounts of directly comparable phenotype data from many mutants, on a genomic scale, to help develop and test new hypotheses about the origins of disease and the normal functions of genes in the organism. Histopathology has a venerable history in the understanding of the pathobiology of human and animal disease, and presents complementary advantages and challenges to in vivo phenotyping. In this review, we present evidence for the unique contribution that histopathology can make to a large-scale phenotyping effort, using examples from past and current programmes at Lexicon Pharmaceuticals and The Jackson Laboratory, and critically assess the role of histopathology analysis in high-throughput phenotyping pipelines. |
format | Online Article Text |
id | pubmed-3255539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The Company of Biologists Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-32555392012-01-31 Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice Schofield, Paul N. Vogel, Peter Gkoutos, Georgios V. Sundberg, John P. Dis Model Mech Special Article Recent advances in gene knockout techniques and the in vivo analysis of mutant mice, together with the advent of large-scale projects for systematic mouse mutagenesis and genome-wide phenotyping, have allowed the creation of platforms for the most complete and systematic analysis of gene function ever undertaken in a vertebrate. The development of high-throughput phenotyping pipelines for these and other large-scale projects allows investigators to search and integrate large amounts of directly comparable phenotype data from many mutants, on a genomic scale, to help develop and test new hypotheses about the origins of disease and the normal functions of genes in the organism. Histopathology has a venerable history in the understanding of the pathobiology of human and animal disease, and presents complementary advantages and challenges to in vivo phenotyping. In this review, we present evidence for the unique contribution that histopathology can make to a large-scale phenotyping effort, using examples from past and current programmes at Lexicon Pharmaceuticals and The Jackson Laboratory, and critically assess the role of histopathology analysis in high-throughput phenotyping pipelines. The Company of Biologists Limited 2012-01 2011-10-25 /pmc/articles/PMC3255539/ /pubmed/22028326 http://dx.doi.org/10.1242/dmm.008334 Text en © 2012. Published by The Company of Biologists Ltd This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium provided that the original work is properly cited and all further distributions of the work or adaptation are subject to the same Creative Commons License terms. |
spellingShingle | Special Article Schofield, Paul N. Vogel, Peter Gkoutos, Georgios V. Sundberg, John P. Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice |
title | Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice |
title_full | Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice |
title_fullStr | Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice |
title_full_unstemmed | Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice |
title_short | Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice |
title_sort | exploring the elephant: histopathology in high-throughput phenotyping of mutant mice |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255539/ https://www.ncbi.nlm.nih.gov/pubmed/22028326 http://dx.doi.org/10.1242/dmm.008334 |
work_keys_str_mv | AT schofieldpauln exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice AT vogelpeter exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice AT gkoutosgeorgiosv exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice AT sundbergjohnp exploringtheelephanthistopathologyinhighthroughputphenotypingofmutantmice |